effusions in mycoplasma and viral pneumonias. N Engl J Med. 1970 Oct 08;283(15):790-3. \[[PubMed: 5456236](https://pubmed.ncbi.nlm.nih.gov/5456236)\] 76. Heffner JE, Brown LK, Barbieri C, DeLeo JM. Pleural fluid chemical analysis in parapneumonic effusions. A meta-analysis. Am J Respir Crit Care Med. 1995 Jun;151(6):1700-8. \[[PubMed: 7767510](https://pubmed.ncbi.nlm.nih.gov/7767510)\] 77. Lodha R, Kabra SK, Pandey RM. Antibiotics for community-acquired pneumonia in children. Cochrane Database Syst Rev. 2013 Jun 04;2013(6):CD004874. \[[PMC free article: PMC7017636](/pmc/articles/PMC7017636/)\] \[[PubMed: 23733365](https://pubmed.ncbi.nlm.nih.gov/23733365)\] 78. Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harrison C, Kaplan SL, Mace SE, McCracken GH, Moore MR, St Peter SD, Stockwell JA, Swanson JT., Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011 Oct;53(7):e25-76. \[[PMC free article: PMC7107838](/pmc/articles/PMC7107838/)\] \[[PubMed: 21880587](https://pubmed.ncbi.nlm.nih.gov/21880587)\] 79. Haider BA, Saeed MA, Bhutta ZA. Short-course versus long-course antibiotic therapy for non-severe community-acquired pneumonia in children aged 2 months to 59 months. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD005976. \[[PubMed: 18425930](https://pubmed.ncbi.nlm.nih.gov/18425930)\] 80. Jones BE, Jones JP, Vines CG, Dean NC. Validating hospital admission criteria for decision support in pneumonia. BMC Pulm Med. 2014 Sep 22;14:149. \[[PMC free article: PMC4189199](/pmc/articles/PMC4189199/)\] \[[PubMed: 25244961](https://pubmed.ncbi.nlm.nih.gov/25244961)\] 81. Najafi S, Sandrock C. Hospitalized Patients with Acute Pneumonia. Hosp Med Clin. 2017 Oct;6(4):456-469. \[[PMC free article: PMC7104154](/pmc/articles/PMC7104154/)\] \[[PubMed: 32288999](https://pubmed.ncbi.nlm.nih.gov/32288999)\] 82. Bradley J, Sbaih N, Chandler TR, Furmanek S, Ramirez JA, Cavallazzi R. Pneumonia Severity Index and CURB-65 Score Are Good Predictors of Mortality in Hospitalized Patients With SARS-CoV-2 Community-Acquired Pneumonia. Chest. 2022 Apr;161(4):927-936. \[[PMC free article: PMC8562015](/pmc/articles/PMC8562015/)\] \[[PubMed: 34740594](https://pubmed.ncbi.nlm.nih.gov/34740594)\] 83. Thomsen RW, Kasatpibal N, Riis A, Nørgaard M, Sørensen HT. The impact of pre-existing heart failure on pneumonia prognosis: population-based cohort study. J Gen Intern Med. 2008 Sep;23(9):1407-13. \[[PMC free article: PMC2517996](/pmc/articles/PMC2517996/)\] \[[PubMed: 18574639](https://pubmed.ncbi.nlm.nih.gov/18574639)\] 84. Martins M, Boavida JM, Raposo JF, Froes F, Nunes B, Ribeiro RT, Macedo MP, Penha-Gonçalves C. Diabetes hinders community-acquired pneumonia outcomes in hospitalized patients. BMJ Open Diabetes Res Care. 2016;4(1):e000181. \[[PMC free article: PMC4879333](/pmc/articles/PMC4879333/)\] \[[PubMed: 27252873](https://pubmed.ncbi.nlm.nih.gov/27252873)\] 85. Glöckner V, Pletz MW, Rohde G, Rupp J, Witzenrath M, Barten-Neiner G, Kolditz M., CAPNETZ Study Group. Early post-discharge mortality in CAP: frequency, risk factors and a prediction tool. Eur J Clin Microbiol Infect Dis. 2022 Apr;41(4):621-630. \[[PMC free article: PMC8934328](/pmc/articles/PMC8934328/)\] \[[PubMed: 35137301](https://pubmed.ncbi.nlm.nih.gov/35137301)\] 86. Garcia-Vidal C, Fernández-Sabé N, Carratalà J, Díaz V, Verdaguer